Tiziana Life Sciences Invited to J.P. Morgan Life Science Forum
Ticker: TLSA · Form: 6-K · Filed: Sep 30, 2025 · CIK: 1723069
Sentiment: neutral
Topics: conference, life-sciences, invitation
TL;DR
Tiziana Life Sciences is heading to the J.P. Morgan LSIF 2025 next week in Saudi Arabia.
AI Summary
Tiziana Life Sciences Ltd. announced on September 30, 2025, that it has been invited to the J.P. Morgan Asset Management, Life Science Innovation Forum (LSIF) 2025. The forum, in collaboration with KAIMRC, will take place from October 1-2, 2025, in Riyadh, Saudi Arabia.
Why It Matters
Participation in this forum provides Tiziana Life Sciences with a platform to showcase its innovations and potentially attract investment or partnerships within the life sciences sector.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in an industry event, which typically carries low immediate risk.
Key Players & Entities
- Tiziana Life Sciences Ltd. (company) — Registrant
- J.P. Morgan Asset Management (company) — Organizer of the Life Science Innovation Forum
- KAIMRC (company) — Collaborator of the Life Science Innovation Forum
- October 1-2, 2025 (date) — Dates of the Life Science Innovation Forum
- September 30, 2025 (date) — Date of the announcement
FAQ
What is the purpose of the J.P. Morgan Asset Management, Life Science Innovation Forum (LSIF) 2025?
The filing states the forum is a platform for innovation within the life sciences sector, with Tiziana Life Sciences being invited to attend.
Who is collaborating with J.P. Morgan Asset Management for this event?
KAIMRC is collaborating with J.P. Morgan Asset Management for the LSIF 2025.
Where will the LSIF 2025 take place?
The LSIF 2025 will take place in Riyadh, Saudi Arabia.
When was this announcement made by Tiziana Life Sciences?
Tiziana Life Sciences made this announcement on September 30, 2025.
What is Tiziana Life Sciences' role at the LSIF 2025?
Tiziana Life Sciences has been invited to attend the LSIF 2025.
Filing Stats: 329 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2025-09-30 08:30:01
Filing Documents
- ea0259453-6k_tiziana.htm (6-K) — 19KB
- ea025945301ex99-1_tiziana.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001213900-25-093428.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: September 30, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated September 30, 2025 3